Inventor

BRAJE WILFRIED

DE56 patents

⚠️ This page may combine multiple inventors who share the name “BRAJE WILFRIED”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRAJE WILFRIED

ABBVIE DEUTSCHLAND

Tricyclic quinoline and quinoxaline derivatives

Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseases

Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators

Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose

Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose

5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases

Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases

Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy

Tricyclic quinoline and quinoxaline derivatives

Modulators of 5-HT receptors and methods of use thereof

Tricyclic quinoline and quinoxaline derivatives

Modulators of 5-HT receptors and methods of use thereof

ABBOTT GMBH & CO KG

Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Pyrimidin-2-one compounds and their use as dopamine D3 receptor ligands

Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor

Pyrimidine compounds and use thereof

Keto lactam compounds and use thereof

Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Dibenzodiazepine derivatives, their preparation and use

BRAJE WILFRIED

5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases

Small molecule potentiators of metabotropic glutamate receptors I

Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

5-halogen-substituted oxindole derivatives and use thereof for treating vasopressin-dependent diseases

1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Small molecule potentiators of metabotropic glutamate receptors

N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor

TURNER SEAN COLM

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor

GENESTE HERVE

Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)

Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor

Pyrimidine compounds and use thereof

DRESCHER KARLA

Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

NETZ ASTRID

Substituted oxindole derivatives and their use as vasopressin receptor ligands

Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases

WANG YING

Modulators of 5-HT receptors and methods of use thereof

Modulators of 5-HT receptors and methods of use thereof

OOST THORSTEN

Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

AMBERG WILHELM

4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy

OCHSE MICHAEL

Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy

ABBVIE INC

Modulators of 5-HT receptors and methods of use thereof

AKRITOPOULOU-ZANZE IRINI

Modulators of 5-HT receptors and methods of use thereof

SCHULTZ THOMAS

Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

UNGER LILIANE

Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor